Monday, December 9, 2019
-18 °c
StockWatch247
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap
No Result
View All Result
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap
No Result
View All Result
StockWatch247
No Result
View All Result
Home Active Stocks

Acasti Pharma (ACST) Trading in a Bullish Channel for Almost Two Months in a Row

by Stock Watch 247 Team
July 23, 2019
in Active Stocks
2 min read
0
NASDAQ: ACST
Share on FacebookShare on Twitter

Acasti Pharma [NASDAQ: ACST] has been one of the biggest gainers in the last 2 months. It started gaining bullish momentum in May and has been gaining ever since. At the time, it was trading at $0.85, and has rose to hit highs of $2.1. Looking at its more short-term price action, there is a possibility that this bullish momentum may continue.

Last week, Acasti was forming higher lows, with the 100-day moving average acting as key support. That’s an indicator that bulls are in control of the market. In intra-day trading, Acasti eased up slightly in Monday’s trading session to hit a low of $1.72. However, it recovered towards the end of the day to close at $1.96.  It’s a positive indicator that bullish momentum is still strong in this stock.

RELATED POSTS

Oramed Pharmaceuticals (NASDAQ: ORMP) a Big Winner Following Japan Success on ORMD-0801

AVX Corporation (NYSE: AVX) Gaps Up on Kyocera Buyout News

There are multiple things that support the bullish sentiment surrounding this stock at the moment. For instance, on the 24th of June, the company announced that it had received an allowance for its second patent in China. The patent is about the company’s concentrated Omega-3 Phospholipid and covers a number of methods used in the treatment of cardiovascular diseases, neurodegenerative diseases among others.  This patent helped strengthen the company’s IP portfolio, and gives it competitive advantage in China, the world’s 3rd largest market for pharmaceuticals. It’s seems to be a huge potential boost to the company’s growth going into the future.

The company also issued its 2019 business update on the 26th of June, and it was positive. Part of the announcement was that, their phase 3 clinical trials had achieved a 100% patient randomization in clinical trials. In terms of finances, the company’s losses rose from $21.5 million to $51.6 million. However, this is due to the research and development costs for the phase 3 program.

Tags: Bullish StocksNASDAQ: ACSTStock Market InvestingStocks to TradeStocks to WatchSwing Trade StocksSwing Trading Stocks
Share2TweetShare

Related Posts

Oramed Pharmaceuticals (NASDAQ: ORMP) a Big Winner Following Japan Success on ORMD-0801
Active Stocks

Oramed Pharmaceuticals (NASDAQ: ORMP) a Big Winner Following Japan Success on ORMD-0801

by Stock Watch 247 Team
1 week ago

Last week was great for Oramed Pharmaceuticals Inc (NASDAQ: ORMP). It rallied all week, and on Friday it closed the...

Read more
AVX Corporation (NYSE: AVX) Gaps Up on Kyocera Buyout News
Active Stocks

AVX Corporation (NYSE: AVX) Gaps Up on Kyocera Buyout News

by Stock Watch 247 Team
2 weeks ago

Active Stocks: AVX Corporation (NYSE: AVX) was one of the big gainers in yesterday’s trading session. This followed news that...

Read more
Proteostasis Therapeutics (NASDAQ: PTI) Gains As It Completes Enrollment For Treatment Study
Active Stocks

Proteostasis Therapeutics (NASDAQ: PTI) Gains As It Completes Enrollment For Treatment Study

by Stock Watch 247 Team
2 weeks ago

Proteostasis Therapeutics Inc (NASDAQ: PTI) was one of the biggest gainers in Tuesday’s trading session. It gained by over 26.98% to...

Read more
Active Stocks: Alibaba Group Holding (NYSE: BABA) Debuts on the Hong Stock Exchange at a Premium
Active Stocks

Active Stocks: Alibaba Group Holding (NYSE: BABA) Debuts on the Hong Stock Exchange at a Premium

by Stock Watch 247 Team
2 weeks ago

Active Stocks: Alibaba Group Holding Limited (NYSE: BABA) is one of the big cap stocks making headlines today. The company...

Read more
Active Stocks: Cancer Genetics (NASDAQ: CGIX) Rallies Over 100% on Positive Q3 Financial Results
Active Stocks

Active Stocks: Cancer Genetics (NASDAQ: CGIX) Rallies Over 100% on Positive Q3 Financial Results

by Stock Watch 247 Team
3 weeks ago

Active Stocks: Cancer Genetics Inc was a big winner in Wednesday’s trading session. The stock gained by 131.25%...

Read more
Next Post
NASDAQ: ARRY

Array Biopharma (ARRY) Made a Parabolic Type Move of Over 80% Since May

NASDAQ: SKIS

Stocks In News: Peak Resort (SKIS) Spikes on Buy Out News from Vail Resort (MTN)

Please login to join discussion

MOST VIEWED

  • NASDAQ: FCEL

    FuelCell Energy (FCEL) Gains by Over 10% in Pre-market Trading

    0 shares
    Share 0 Tweet 0
  • JUMIA TECHNOLOGIES AG (JMIA) After IPO Surge Ends as The Stock Sees a 13% Slump

    0 shares
    Share 0 Tweet 0
  • Amazon (AMZN) – Amazon likely to stay bullish this quarter: The fundamentals support it

    1 shares
    Share 1 Tweet 0
  • Tufin Software Technologies (TUFN) Continues to Show Strength in the Market

    2 shares
    Share 2 Tweet 0
  • Jumia Technologies AG (JMIA) Stock: Likely the Undiscovered Africa’s New ‘Gold’

    0 shares
    Share 0 Tweet 0

Stock Watch 247

Stock Watch 247 is a leading provider and publisher of stock market news, initial public offering (IPO) news, new stock listings and stocks to watch, commentary, business news, financial news and content on the USA & World Markets. Stock Watch 247 is for information only and not investment advice. Please make sure to read our Disclaimer and Privacy Policy. We may be buying or selling any stock discussed at any time.

Categories

  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap

Stitch Fix (SFIX) Earnings Beat Analyst Expectations – Bullish Sentiment Building Up in Pre-Market Trading

Viomi Technology Company Ltd (VIOT) – A Unicorn that continues to excite the market

Stocks To Watch: Arcadia Biosciences (RKDA) HB4 Approval Triggers Run and Short Squeeze

United States Steel Corporation (X) Defies the Odds, Stays Green ahead of Ex-Dividend May 10 Trading

Restoration Hardware Holdings (RH) Beats Analysts’ Expectations and Surges by Over 20%

GoPro (GPRO) HERO7 Black Camera helps Push and Drive Up Revenues in Q1

SUBSCRIBE TO OUR FREE VIP NEWSLETTER: Get Trade Reports, Ideas, Breaking News and more!

By clicking "Subscribe" I agree to the Privacy Policy & Disclaimer presented on this site.

  • About Us
  • Our Team
  • Privacy Policy
  • Disclaimer
  • Contact Us

© 2019 StockWatch247 - Copyright © All Rights Reserved.

No Result
View All Result
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap

© 2019 StockWatch247 - Copyright © All Rights Reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In